<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d00b/9573926/96f547002d52/gr8.jpg"/> </div> <div class="text-side"> <h1>Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells.</h1> <p>H&amp;E staining images of mouse skin painted with lorglumide. Lorglumide dissolved in aqueous cream (400 μg/mouse) or aqueous cream (control) was applied epicutaneously onto the skin of the left frank five times a week. Twelve days later, the skin was excised and stained with H&amp;E. Images are representative of two independent experiments (two mice per group). Bar = 100 μm.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36262666/" target="_blank">36262666</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>